FineMark National Bank & Trust’s DexCom DXCM Stock Holding History

FineMark National Bank & Trust’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,752	Closed	-$26K	–	545
2016 Q4	$26K	Hold	1,752	–	–	﹤0.01%	768
2016 Q3	$38K	Buy	1,752 +12	+0.7%	+$267	﹤0.01%	672
2016 Q2	$35K	Hold	1,740	–	–	﹤0.01%	694
2016 Q1	$30K	Hold	1,740	–	–	﹤0.01%	704
2015 Q4	$36K	Hold	1,740	–	–	﹤0.01%	677
2015 Q3	$37K	Hold	1,740	–	–	0.01%	700
2015 Q2	$35K	Hold	1,740	–	–	﹤0.01%	747
2015 Q1	$27K	Sell	1,740 -400	-19%	-$6.04K	﹤0.01%	810
2014 Q4	$30K	Hold	2,140	–	–	﹤0.01%	805
2014 Q3	$21K	Buy	+2,140	New	+$21.9K	﹤0.01%	874
2014 Q2	–	Sell	-2,000	Closed	-$21K	–	1409
2014 Q1	$21K	Buy	2,000 +800	+67%	+$8.27K	﹤0.01%	869
2013 Q4	$11K	Buy	1,200 +400	+50%	+$3.17K	﹤0.01%	995
2013 Q3	$6K	Hold	800	–	–	﹤0.01%	1065
2013 Q2	$4K	Buy	+800	New	+$3.83K	﹤0.01%	1136

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

FineMark National Bank & Trust's DXCM Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of DexCom (DXCM) in Q1 2017, closing a stake of 1,752 shares — an estimated $26K sold.

FineMark National Bank & Trust first reported a position in DXCM in Q2 2013 and held it in 14 quarters. The position peaked at $38K in Q3 2016. 321 funds tracked by Wall St. Rank hold DXCM as of Q1 2017.

FineMark National Bank & Trust reported no remaining DexCom position as of Q1 2017 after selling out during the quarter.
FineMark National Bank & Trust sold 1,752 DexCom shares in Q1 2017, an estimated $26K.
FineMark National Bank & Trust first reported a position in DexCom in Q2 2013 and held it in 14 quarters.
FineMark National Bank & Trust's DexCom position peaked at $38K in Q3 2016.
321 funds tracked by Wall St. Rank held DexCom as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.